Search
01/03/2022
Neuropsychological deficits in patients with cognitive complaints after COVID-19
Garcia-Sanchez, C, Calabria, M, Grunden, N, Pons, C, Arroyo, JA, Gomez-Anson, B, Lleo, A, Alcolea, D, Belvis, R, Morollon, N, Mur, I, Pomar, V, Domingo, P. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain and Behavior. 2022; 12(3)DOI:10.1002/brb3.2508. PMID:35137561. IF:3.100(Q2/3D).
09/02/2022
Cortical microstructure in primary progressive aphasia: a multicenter study
Illan-Gala, I, Montal, V, Borrego-Ecija, S, Mandelli, ML, Falgas, N, Welch, AE, Pegueroles, J, Santos-Santos, M, Bejanin, A, Alcolea, D, Dols-Icardo, O, Belbin, O, Sanchez-Saudinos, MB, Bargallo, N, Gonzalez-Ortiz, S, Llado, A, Blesa, R, Dickerson, BC, Rosen, HJ, Miller, BL, Lleo, A, Gorno-Tempini, ML, Sanchez-Valle, R, Fortea, J. Cortical microstructure in primary progressive aphasia: a multicenter study. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-00974-0. PMID:35139897. IF:9.000(Q1/1D).
01/02/2022
Fluid markers of synapse degeneration in synucleinopathies
Gonzalez, AC, Belbin, O. Fluid markers of synapse degeneration in synucleinopathies. JOURNAL OF NEURAL TRANSMISSION. 2022; 129(2)DOI:10.1007/s00702-022-02467-8. PMID:35147800. IF:3.300(Q2/5D).
01/02/2022
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
Delaby, C, Alcolea, D, Hirtz, C, Vialaret, J, Kindermans, J, Morichon, L, Fortea, J, Belbin, O, Gabelle, A, Blennow, K, Zetterberg, H, Lleo, A, Lehmann, S. Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles. JOURNAL OF NEURAL TRANSMISSION. 2022; 129(2)DOI:10.1007/s00702-022-02474-9. PMID:35169889. IF:3.300(Q2/5D).
01/02/2022
The A beta 1-42/A beta 1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than A beta 1-42 alone
Delaby, C, Estelles, T, Zhu, NU, Arranz, J, Barroeta, I, Carmona-Iragui, M, Illan-Gala, I, Santos-Santos, MA, Altuna, M, Sala, I, Sanchez-Saudinos, MB, Videla, L, Valldeneu, S, Subirana, A, Tondo, M, Blanco-Vaca, F, Lehmann, S, Belbin, O, Blesa, R, Fortea, J, Lleo, A, Alcolea, D. The A beta 1-42/A beta 1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than A beta 1-42 alone. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-00967-z. PMID:35105351. IF:9.000(Q1/1D).
01/02/2022
Proteinopathies: molecular mechanisms and diagnostic perspectives (vol 129, pg 129, 2022)
Delaby, C, Lehmann, S. Proteinopathies: molecular mechanisms and diagnostic perspectives (vol 129, pg 129, 2022). JOURNAL OF NEURAL TRANSMISSION. 2022; 129(2)DOI:10.1007/s00702-022-02473-w. PMID:35175386. IF:3.300(Q2/5D).